Mebanazine
From Wikipedia, the free encyclopedia
![]() |
|
Systematic (IUPAC) name | |
---|---|
1-phenylethylhydrazine
|
|
Clinical data | |
Routes of administration |
Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 65-64-5 |
ATC code | none |
PubChem | CID 6179 |
ChemSpider | 5944 |
UNII | Z5R55CJ4CG ![]() |
ChEMBL | CHEMBL1909283 |
Chemical data | |
Formula | C8H12N2 |
Molar mass | 136.19 g/mol |
Mebanazine (trade name Actomol) is a monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was previously used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]
See also[edit]
References[edit]
- ^ Gilmour SJ (September 1965). "Clinical trial of mebanazine--a new monoamine oxidase inhibitor". The British Journal of Psychiatry. 111 (478): 899–902. doi:10.1192/bjp.111.478.899. PMID 5889715.
- ^ Barker JC, Jan IA, Enoch MD (November 1965). "A controlled trial of mebanazine ('Actomol') in depression". The British Journal of Psychiatry. 111 (480): 1095–100. doi:10.1192/bjp.111.480.1095. PMID 5320546.
- ^ Knott F (1965). "A preliminary trial of mebanazine in depressive states". The Journal of New Drugs. 5 (6): 345–7. doi:10.1002/j.1552-4604.1965.tb00259.x. PMID 5327282.
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |